Abstract
One of the most common hepatic manifestations of the metabolic syndrome is non-alcoholic fatty liver disease (NAFLD). This disease varies from simple steatosis to cirrhosis and hepatocellular carcinoma. Different molecules secreted from adipose tissue such as adiponectin, leptin, resistin and visfatin and pro-inflammatory cytokines such as tumour necrosis factor-α, and interleukins, can be involved in the pathogenesis of NAFLD. In this review we describe the role of these adipokines and cytokines in the pathogenesis of NAFLD. We comment on their potential use as non-invasive biomarkers of steatosis and fibrosis, and their potential therapeutic role.
Keywords: Adipokines, cytokines, fibrosis, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, steatosis.
Reviews on Recent Clinical Trials
Title:Role of Adipokines and Cytokines in Non-alcoholic Fatty Liver Disease
Volume: 9 Issue: 3
Author(s): Ludovico Abenavoli and Valentina Peta
Affiliation:
Keywords: Adipokines, cytokines, fibrosis, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, steatosis.
Abstract: One of the most common hepatic manifestations of the metabolic syndrome is non-alcoholic fatty liver disease (NAFLD). This disease varies from simple steatosis to cirrhosis and hepatocellular carcinoma. Different molecules secreted from adipose tissue such as adiponectin, leptin, resistin and visfatin and pro-inflammatory cytokines such as tumour necrosis factor-α, and interleukins, can be involved in the pathogenesis of NAFLD. In this review we describe the role of these adipokines and cytokines in the pathogenesis of NAFLD. We comment on their potential use as non-invasive biomarkers of steatosis and fibrosis, and their potential therapeutic role.
Export Options
About this article
Cite this article as:
Abenavoli Ludovico and Peta Valentina, Role of Adipokines and Cytokines in Non-alcoholic Fatty Liver Disease, Reviews on Recent Clinical Trials 2014; 9 (3) . https://dx.doi.org/10.2174/1574887109666141216102458
DOI https://dx.doi.org/10.2174/1574887109666141216102458 |
Print ISSN 1574-8871 |
Publisher Name Bentham Science Publisher |
Online ISSN 1876-1038 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Inhaled Nitric Oxide in Preterm Neonates with Refractory Hypoxemia Associated to Oligohydramnios
Current Drug Discovery Technologies Hypertension in Type 2 Diabetes Mellitus: Do We Need to Redefine the Role of Sulfonylureas?
Recent Advances in Cardiovascular Drug Discovery (Discontinued) Pathogenesis and Immune Status in COVID-19 Pneumonia - A Minireview
Coronaviruses Current Perspectives on Hypertension in Asian Indians
Current Hypertension Reviews Uric acid and Metabolic Syndrome: What is the Relationship?
Current Rheumatology Reviews On the Analysis of Fingertip Photoplethysmogram Signals
Current Cardiology Reviews Insulin Neuritis and Diabetic Cachectic Neuropathy: A Review
Current Diabetes Reviews Editorial [Hot topic: Psychotropic Drugs in Child and Adolescent Psychiatry - a New Era on the Horizon (Executive Editors: Aribert Rothenberger, Manfred Gerlach and Ralf W. Dittmann)]
Current Pharmaceutical Design Traditional and Novel Risk Factors of Diabetic Retinopathy and Research Challenges
Current Medicinal Chemistry Complications Associated with Recombinant Tissue Plasminogen Activator Therapy for Acute Ischaemic Stroke
CNS & Neurological Disorders - Drug Targets Use of Diuretics in Women for Management of Hypertension
Current Hypertension Reviews Systematic Review of the Role of Microparticles in Systemic Sclerosis
Current Rheumatology Reviews Life and Death Partners in Post-PCI Restenosis: Apoptosis, Autophagy, and The Cross-talk Between Them
Current Drug Targets Editorial [Hot Topic: Modifying Cardiovascular Risk Factors: Epidemiology and Characteristics of Hypertension-Related Disorders (Executive Guest Editor: Aurelio Leone)]
Current Pharmaceutical Design Diabetes Type 4: A Paradigm Shift in the Understanding of Glaucoma, the Brain Specific Diabetes and the Candidature of Insulin as a Therapeutic Agent
Current Molecular Medicine Thymosin β4 Protein Therapy for Cardiac Repair
Current Pharmaceutical Design Anti-Hypertensive Potential and Epigenetics of Angiotensin II type 2 Receptor (AT2R)
Current Hypertension Reviews Inflammatory Biomarkers in Chronic Kidney Disease: A Review
Recent Patents on Biomarkers Treatment of Cardiovascular Risk Factors in Women
Current Medicinal Chemistry Different Lifestyles in Young Women From Urban and Rural Areas May Explain Different Cardiovascular Risk
Vascular Disease Prevention (Discontinued)